How to determine optimal treatment for de novo metastatic breast cancer

Fumiko Ladd Chino shared a post on X:

“Dr Jennifer Plichta, Duke Cancer Breast Surgical Oncology Grand Rounds MD Anderson Cancer Center  today discussing how to determine optimal treatment for de novo metastatic breast cancer . Don’t count out MBC stageIV. We need better trials and better data collection!

Novel Prognostic Staging System for Patients With De Novo Metastatic Breast Cancer

Authors: Jennifer K Plichta, Samantha M Thomas, Daniel F Hayes, Mariana Chavez-MacGregor, Kimberly Allison, Jennifer de Los Santos, Amy M Fowler, Armando E Giuliano, Priyanka Sharma, Benjamin D Smith, Elizabeth van Eycken, Stephen B Edge, Gabriel N Hortobagyi.”

Fumiko Ladd Chino is an attending in Radiation Oncology at MD Anderson Cancer Center, who specializes in gynecological and breast cancers. She was also a caregiver for her husband Andrew Mark Ladd, PhD who died from cancer in 2007. She is a recipient of numerous awards, including ASCO Excellence in Equity Award (2022), Duke Radiation Oncology Award for Outstanding Clinical Research (2019), Duke University Hospital “Good Catch” Award (2018), Conquer Cancer Foundation of ASCO Merit Award (2018), Duke University School of Medicine Dean’s Recognition Award (2014) and Memorial Hermann Hospital, Texas Medical Center Volunteer of the Year Award (2009).